insights_auto
Kwa nini ALNY imeongezeka kwa 3.63%?
Fahamu zaidichevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
US$ 232.68
arrow_upward
+3.63%(+8.15) Siku 1
9 Okt, 16:00:01 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALNY...
Fungua
US$ 224.74
Juu
US$ 232.94
Chini
US$ 222.70
Mtaji wa soko
31.13B
Wastani wa kiasi cha mauzo
1.50M
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
39.60
Juu kwa wiki 52
US$ 495.55
Chini kwa wiki 52
US$ 197.81
EPS
US$ 5.88
Beta
0.28
Hisa za wawekezaji
133.81M
Idadi ya wafanyakazi
elfu 2
Fungua
US$ 224.74
Juu
US$ 232.94
Chini
US$ 222.70
Mtaji wa soko
31.13B
Wastani wa kiasi cha mauzo
1.50M
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
39.60
Juu kwa wiki 52
US$ 495.55
Chini kwa wiki 52
US$ 197.81
EPS
US$ 5.88
Beta
0.28
Hisa za wawekezaji
133.81M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Investing.com
·
saa 17 zilizopita
Alnylam EVP Bryan Supran sells $398,855 in shares
Investing.com Nigeria
·
saa 17 zilizopita
Form 4 Alnylam Pharmaceuticals Inc For: 11 October By Investing.com
Simply Wall Street
·
saa 18 zilizopita
How Securities Fraud Scrutiny Will Impact Alnylam Stock Investors
Stock Traders Daily
·
siku 1 iliyopita
(ALNY) Price Dynamics and Execution-Aware Positioning
Wasifu
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Kuhusu Alnylam Pharmaceuticals, Inc.
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 2.5
Lilianzishwa14 Jun 2002
Makao makuu-
Sekta-
Tovutialnylam.com